Sustained release comfort formulation for glaucoma therapy

Details Sustained release comfort formulation for glaucoma therapy Sustained release comfort formulation for glaucoma therapy

1995-02-27

1997-06-03

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Topical body preparation containing solid synthetic organic...

Ophthalmic preparation

424 7812, 424 7816, 514913, A61K 3178

Patent

active

056351720

ABSTRACT:
Disclosed are nonstinging, sustained release ophthalmic formulations to control intraocular pressure in antiglaucoma therapy comprising a basic active, a cation exchange resin, and, inter alia, an acidic, mucomimetic polymer. Also disclosed are methods of treatment comprising administering such formulations topically to the eye when indicated for control and lowering of intraocular pressure.

REFERENCES:
Stalker Dissertation, (1983).

Affiliated with

Also associated with

Rating

Sustained release comfort formulation for glaucoma therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release comfort formulation for glaucoma therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release comfort formulation for glaucoma therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-389342